ArticleAnnals of transplantation2025
Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center Experience.
Article in Annals of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Simultaneous liver-kidney transplantation (SLKT) is a complex procedure essential for patients with end-stage liver and kidney disease. Most SLKT outcome reports originate from large transplant centers in developed countries, with limited data from Latin America. This study aimed to describe SLKT outcomes at a high-complexity center in Colombia to assess their comparability with existing literature. MATERIAL AND METHODS A retrospective, single-center study included adult and pediatric patients who underwent SLKT between January 2005 and December 2023. Data on demographics, perioperative status, in-hospital course, and follow-up outcomes were collected from hospital databases and medical records. Kaplan-Meier survival analysis and descriptive statistics were utilized. RESULTS During the study, 41 SLKTs were performer - 31 in adults and 10 in children - accounting for 4.18% of liver transplants and 5.73% of kidney transplants. Alcoholic cirrhosis was the primary indication for adult liver transplants (38.7%), while congenital hepatic fibrosis was prevalent in children (50%). Diabetic nephropathy was the leading cause of adult kidney disease (48.3%), with nephronophthisis and polycystic kidney disease common in pediatric cases (30% each). All adult grafts were from deceased donors; 50% of pediatric cases used living donors. No intraoperative dialysis was required. Four early postoperative deaths occurred due to sepsis and multiple organ failure. Survival rates at 1, 3, and 5 years were 92.6%, 80.4%, and 75.6%, respectively. CONCLUSIONS SLKT outcomes at the institution are satisfactory and comparable to other series, though pediatric patients face a higher risk of early septic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.